Julissa Viana

Equibles does not estimate personal net worth.

Get an email with a short summary when Verastem, Inc. publishes a filing, an earnings call transcript or a press release.

Get VSTM alerts

About Julissa Viana

Julissa Viana has spoken on 4 earnings calls and 1 other investor event across 1 company, most recently for Verastem, Inc. on August 6, 2026. Verastem, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Verastem, Inc. includes Brian M. Stuglik (CEO), Daniel Paterson (CEO and Board Member), Michael Bailey (CEO) and 7 others.

Julissa Viana on recent calls

“Welcome, everyone, and thank you for joining us today to discuss Veristem's second quarter 2026 financial results and recent business updates. This afternoon, we issued a press release detailing these results, along with a slide presentation that we will reference during our call today.”

Head of Investor Relations, Verastem Oncology 2Q26 Earnings Call · August 6, 2026

“Welcome, everyone, and thank you for joining us today to discuss our potential best-in-class, highly selective oral KRAS G12D on-off inhibitor, VS7375. We will share progress from our Target D Clinical Development Program, including preliminary data from the Target D-101 dose escalation and dose expansion trial.”

Head of Investor Relations, Verastem Oncology VS-7375 TARGET-D Conference Call · June 23, 2026

“Welcome, everyone, and thank you for joining us today to discuss VeriStem's first quarter 2026 financial results and recent business updates. This afternoon, we issued a press release detailing these results, along with the slide presentations that will be referenced during our call today.”

Head of Investor Relations, Verastem, Inc. Q1 FY2026 Earnings Call · May 7, 2026

“Welcome, everyone, and thank you for joining us today to discuss Veristam's fourth quarter and full year 2025 financial results and recent business updates. This afternoon, we issued a press release detailing these results, along with a slide presentation that we will reference during our call today.”

Head of Investor Relations, Verastem, Inc. Q4 FY2025 Earnings Call · March 4, 2026

“Welcome, everyone, and thank you for joining us today to discuss Verisim's third quarter 2025 financial results and recent visit updates. This morning, we issued a press release detailing our financial results for the quarter and year-to-date.”

Head of Investor Relations, Verastem, Inc. Q3 FY2025 Earnings Call · November 4, 2025